Literature DB >> 19273166

Cognitive and limbic circuits that are affected by deep brain stimulation.

Suzanne N Haber1, Justin L Brucker.   

Abstract

Several lines of evidence indicate that the neural network that underlies the pathophysiology of obsessive-compulsive disorder and depression centers on the prefronto-basal ganglia system. Particularly involved are anterior cingulate cortex, the orbital prefrontal cortex, the ventral striatum, and parts of the thalamus. Additional integral parts of the network include, the amygdala, the midbrain dopamine cells and the serotonergic neurons. Collectively, these brain regions are involved in various aspects of reward-based learning and good decision-making skills. They are also associated with sadness and depression, pathological risk-taking, addictive behaviors, and obsessive-compulsive disorder. Two of the most successful deep brain stimulation targets for obsessive-compulsive disorder and depression are centered in white matter tracts. These targets were chosen for their central location and ability to capture specific ascending and descending connections, with a particular focus on fibers connecting the subgenual anterior cingulate and orbital cortex with the basal ganglia, thalamus, and amygdala. As more knowledge is obtained concerning the details of these connections, more precise targets may be possible.

Entities:  

Mesh:

Year:  2009        PMID: 19273166     DOI: 10.2741/3344

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  13 in total

1.  Building a neuroscience of pleasure and well-being.

Authors:  Kent C Berridge; Morten L Kringelbach
Journal:  Psychol Well Being       Date:  2011-10-24

2.  Anatomical connectivity between subcortical structures.

Authors:  Kyle Taljan; Cameron McIntyre; Ken Sakaie
Journal:  Brain Connect       Date:  2011

3.  Axonal pathways linked to therapeutic and nontherapeutic outcomes during psychiatric deep brain stimulation.

Authors:  J Luis Lujan; Ashutosh Chaturvedi; Donald A Malone; Ali R Rezai; Andre G Machado; Cameron C McIntyre
Journal:  Hum Brain Mapp       Date:  2011-04-21       Impact factor: 5.038

4.  Disruptions in functional network connectivity during alcohol intoxicated driving.

Authors:  Catherine I Rzepecki-Smith; Shashwath A Meda; Vince D Calhoun; Michael C Stevens; Madiha J Jafri; Robert S Astur; Godfrey D Pearlson
Journal:  Alcohol Clin Exp Res       Date:  2009-12-17       Impact factor: 3.455

5.  Lesion analysis for cingulotomy and limbic leucotomy: comparison and correlation with clinical outcomes.

Authors:  Nikos Makris; Emad N Eskandar; Jimmy C Yang; Daniel T Ginat; Darin D Dougherty
Journal:  J Neurosurg       Date:  2013-11-15       Impact factor: 5.115

Review 6.  Attention-deficit/hyperactivity disorder and attention networks.

Authors:  George Bush
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

7.  Multi-tensor investigation of orbitofrontal cortex tracts affected in subcaudate tractotomy.

Authors:  Jimmy C Yang; George Papadimitriou; Ryan Eckbo; Edward H Yeterian; Lichen Liang; Darin D Dougherty; Sylvain Bouix; Yogesh Rathi; Martha Shenton; Marek Kubicki; Emad N Eskandar; Nikos Makris
Journal:  Brain Imaging Behav       Date:  2015-06       Impact factor: 3.978

8.  Deep brain stimulation in the central nucleus of the amygdala decreases 'wanting' and 'liking' of food rewards.

Authors:  Shani E Ross; Emily Lehmann Levin; Christy A Itoga; Chelsea B Schoen; Romeissa Selmane; J Wayne Aldridge
Journal:  Eur J Neurosci       Date:  2016-08-05       Impact factor: 3.386

9.  Mechanisms of deep brain stimulation for obsessive compulsive disorder: effects upon cells and circuits.

Authors:  Sarah K Bourne; Christine A Eckhardt; Sameer A Sheth; Emad N Eskandar
Journal:  Front Integr Neurosci       Date:  2012-06-14

10.  Genetically determined dopamine availability predicts disposition for depression.

Authors:  Andrea Felten; Christian Montag; Sebastian Markett; Nora T Walter; Martin Reuter
Journal:  Brain Behav       Date:  2011-11       Impact factor: 2.708

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.